BMY vs SDGR · P/E 17, rev $48.19B vs rev $255.9M
Bristol-Myers Squibb Company (BMY) versus Schrodinger Inc (SDGR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Schrodinger Inc (SDGR) is a health information services company listed on NASDAQ.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported SDGR revenue for 2025-12-31 was $255.9M. Net income was -$103.3M. Revenue was up 23.3% from 2024-12-31 to 2025-12-31. SDGR currently screens at market cap $1.16B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. SDGR currently screens at market cap $1.16B.
Not investment advice. Open the BMY and SDGR stock pages for the full models.
Not investment advice.